Spots Global Cancer Trial Database for hemodialysis
Every month we try and update this database with for hemodialysis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D | NCT00977080 | Chronic Kidney ... Secondary Hyper... Hemodialysis | Paricalcitol Cinacalcet | 18 Years - | Abbott | |
| Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism | NCT01341782 | Secondary Hyper... Hemodialysis | paricalcitol maxacalcitol paricalcitol pl... maxacalcitol pl... | 20 Years - | AbbVie | |
| Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis | NCT01181531 | Hyperparathyroi... | Traditional Vit... Cinacalcet | 18 Years - | Amgen | |
| A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis | NCT01922843 | Hyperparathyroi... Kidney Failure,... | DP001 softgel c... Placebo | 18 Years - | Deltanoid Pharmaceuticals | |
| Treatment of Secondary Hyperparathyroidism in the Uremic Patient | NCT00469599 | Secondary Hyper... Chronic Kidney ... Vitamin D Defic... | paricalcitol alfacalcidol | 18 Years - | Zealand University Hospital | |
| European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy | NCT00700531 | Multiple Myelom... Cast Nephropath... Kidney Failure | FLC removal HD ... Standard dialys... | 18 Years - | University Hospital Birmingham | |
| Stellate Ganglion Block for Preserving Arteriovenous Fistula in Hemodialysis Patients Undergoing Major Lower Limb Orthopedic Surgery | NCT06300658 | Stellate Gangli... Arteriovenous F... Hemodialysis Major Lower Lim... | Stellate gangli... | 21 Years - 75 Years | Aswan University | |
| Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose | NCT00891813 | Secondary Hyper... Renal Insuffici... Parathyroid Hor... Hemodialysis Hypercalcemia | Zemplar (parica... | 18 Years - | Abbott | |
| Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose | NCT00891813 | Secondary Hyper... Renal Insuffici... Parathyroid Hor... Hemodialysis Hypercalcemia | Zemplar (parica... | 18 Years - | Abbott | |
| The ICALIC 2 International Multicentric Study | NCT03947294 | Cancer Surgery Hemodialysis | Q-NRG® | 18 Years - | University Hospital, Geneva | |
| Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism | NCT01439867 | Chronic Kidney ... Hyperparathyroi... | Cinacalcet hydr... Standard of Car... | 28 Days - 2189 Days | Amgen | |
| Treatment of Secondary Hyperparathyroidism in the Uremic Patient | NCT00469599 | Secondary Hyper... Chronic Kidney ... Vitamin D Defic... | paricalcitol alfacalcidol | 18 Years - | Zealand University Hospital | |
| Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D | NCT00977080 | Chronic Kidney ... Secondary Hyper... Hemodialysis | Paricalcitol Cinacalcet | 18 Years - | Abbott | |
| Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism | NCT00990704 | Secondary Hyper... Hemodialysis | paricalcitol maxacalcitol | 20 Years - | Abbott | |
| Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury | NCT05429515 | Multiple Myelom... Acute Kidney In... Hemodiafiltrati... | HFR-SUPRA hemodialysis Chemotherapy | 18 Years - 80 Years | Peking Union Medical College Hospital | |
| A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis | NCT01922843 | Hyperparathyroi... Kidney Failure,... | DP001 softgel c... Placebo | 18 Years - | Deltanoid Pharmaceuticals | |
| Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism | NCT01439867 | Chronic Kidney ... Hyperparathyroi... | Cinacalcet hydr... Standard of Car... | 28 Days - 2189 Days | Amgen | |
| Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism | NCT00990704 | Secondary Hyper... Hemodialysis | paricalcitol maxacalcitol | 20 Years - | Abbott | |
| Stellate Ganglion Block for Preserving Arteriovenous Fistula in Hemodialysis Patients Undergoing Major Lower Limb Orthopedic Surgery | NCT06300658 | Stellate Gangli... Arteriovenous F... Hemodialysis Major Lower Lim... | Stellate gangli... | 21 Years - 75 Years | Aswan University | |
| START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism | NCT00132431 | Kidney Disease Secondary Hyper... Chronic Kidney ... | Sensipar | 18 Years - | Amgen | |
| Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis | NCT00667576 | Chronic Kidney ... Secondary Hyper... | Maxacalcitol Paricalcitol | 20 Years - | Abbott | |
| Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis | NCT04709770 | Chronic Kidney ... Colon Polyp Dialysis; Compl... Colon Cancer | 2-liters polyet... 4-liters polyet... Low-residue die... | 18 Years - | University of Bari | |
| Pediatric Chronic Kidney Disease Safety and Efficacy | NCT01277510 | Chronic Kidney ... Hyperparathyroi... Hyperparathyroi... Kidney Disease Secondary Hyper... | cinacalcet caps... placebo Standard of Car... | 6 Years - 17 Years | Amgen | |
| Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD) | NCT00701805 | Secondary Hyper... Hemodialysis | Paricalcitol | 20 Years - | Abbott | |
| Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism | NCT00990704 | Secondary Hyper... Hemodialysis | paricalcitol maxacalcitol | 20 Years - | Abbott | |
| Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD) | NCT00701805 | Secondary Hyper... Hemodialysis | Paricalcitol | 20 Years - | Abbott |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
